Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn New India Regulatory News (ANII)

Share Price Information for Abrdn New India (ANII)

Share Price is delayed by 15 minutes
Get Live Data
662.00    -2.00 (-0.30%)
Bid:
658.00
Ask:
668.00
Spread: 10.00 (1.52%)
Market Cap: £286.90m
ANII Live PriceLast checked at - London Stock Exchange

Intraday Abrdn New India Share Chart

Directorate Changes

1 Apr 2026 07:00

RNS Number : 9243Y
Aberdeen New India Investment Trust
01 April 2026
 

ABERDEEN NEW INDIA INVESTMENT TRUST PLC

LEI - 549300D2AW66WYEVKF02

 

 

1 April 2026

 

Appointment of Non-Executive Director

 

The Board of Aberdeen New India Investment Trust PLC (the "Company") is pleased to announce the appointment of Francesca Ecsery as an independent non-executive Director of the Company with effect from 1 April 2026 following a search conducted by an independent recruitment consultancy.

 

Francesca Ecsery has over 30 years' experience working in both blue-chip companies and start-ups and has special expertise in multiplatform consumer marketing, branding and commercial strategies. She is a non-executive director of Haffner Energy S.A., Air France S.A. and Henderson High Income Trust plc.

 

Francesca was previously a non-executive director at F&C Investment Trust PLC, the Association of Investment Companies (AIC), Marshall Motor Holdings PLC, Share PLC and Good Energy Group PLC and has held various senior positions in consumer-focused industries including the digital, retail and leisure and travel sectors. Her previous executive roles include McKinsey, PepsiCo, Thorn EMI, Thomas Cook and STA Travel.

 

There are no other disclosures required to be made for Francesca Ecsery in respect of paragraphs UKLR 6.4.8R (1) - (6) of the Financial Conduct Authority's Listing Rules.

 

Francesca Ecsery, or her persons closely associated, has no interest in the shares of the Company.

 

Appointment of Chairman and Senior Independent Director

 

As set out in the Annual Report for the year ended 31 March 2025, Michael Hughes retired as Chairman of the Board and as a Director of the Company on 31 March 2026.

 

With effect from 1 April 2026, David Simpson is appointed Chairman of the Board, Andrew Robson is appointed Senior Independent Director and Irina Miklavchich is appointed Chair of the Management Engagement Committee.

 

 

For further information, please contact:

 

Stuart Reid

abrdn Holdings Limited

Secretaries

 

Email:  cef.cosec@aberdeenplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAJBMFTMTBJBRF
Date   Source Headline
28th Jan 202611:35 amRNSNet Asset Value(s)
27th Jan 20265:14 pmRNSTransaction in Own Shares
27th Jan 202611:46 amRNSNet Asset Value(s)
26th Jan 20265:20 pmRNSTransaction in Own Shares
26th Jan 20262:37 pmRNSGearing disclosure
26th Jan 202612:25 pmRNSNet Asset Value(s)
23rd Jan 20265:07 pmRNSTransaction in Own Shares
23rd Jan 202612:27 pmRNSNet Asset Value(s)
22nd Jan 20265:12 pmRNSTransaction in Own Shares
22nd Jan 20261:10 pmRNSHolding(s) in Company
22nd Jan 202611:50 amRNSNet Asset Value(s)
21st Jan 20265:09 pmRNSTransaction in Own Shares
21st Jan 202611:57 amRNSNet Asset Value(s)
20th Jan 20265:07 pmRNSTransaction in Own Shares
20th Jan 20264:10 pmRNSHolding(s) in Company
20th Jan 202612:04 pmRNSNet Asset Value(s)
19th Jan 20262:44 pmRNSGearing disclosure
19th Jan 202612:27 pmRNSNet Asset Value(s)
16th Jan 20265:07 pmRNSTransaction in Own Shares
16th Jan 202610:44 amRNSNet Asset Value(s)
15th Jan 20265:07 pmRNSTransaction in Own Shares
15th Jan 202611:07 amRNSNet Asset Value(s)
14th Jan 20265:18 pmRNSTransaction in Own Shares
14th Jan 202611:35 amRNSNet Asset Value(s)
13th Jan 20265:06 pmRNSTransaction in Own Shares
13th Jan 202611:22 amRNSNet Asset Value(s)
12th Jan 20265:09 pmRNSTransaction in Own Shares
12th Jan 20261:04 pmRNSGearing disclosure
12th Jan 202612:11 pmRNSNet Asset Value(s)
12th Jan 20269:38 amRNSPortfolio disclosure
9th Jan 20265:16 pmRNSTransaction in Own Shares
9th Jan 20263:48 pmRNSHolding(s) in Company
9th Jan 202612:16 pmRNSNet Asset Value(s)
8th Jan 20265:21 pmRNSTransaction in Own Shares
8th Jan 20264:21 pmRNSHolding(s) in Company
8th Jan 202611:33 amRNSNet Asset Value(s)
7th Jan 20265:16 pmRNSTransaction in Own Shares
7th Jan 202611:40 amRNSNet Asset Value(s)
6th Jan 20265:38 pmRNSMonth End Net Asset Value(s)
6th Jan 20265:15 pmRNSTransaction in Own Shares
6th Jan 202611:26 amRNSQuarterly disclosure
6th Jan 202611:16 amRNSNet Asset Value(s)
5th Jan 20261:06 pmRNSGearing disclosure
5th Jan 202612:29 pmRNSNet Asset Value(s)
2nd Jan 20269:52 amRNSTotal Voting Rights
2nd Jan 20269:14 amRNSBlock listing Interim Review
31st Dec 202511:14 amRNSNet Asset Value(s)
30th Dec 20255:08 pmRNSTransaction in Own Shares
30th Dec 20255:08 pmRNSTransaction in Own Shares
30th Dec 202511:30 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.